Pre-Market Runners – 09/13/21

HOT STOCKS FOR YOUR MORNING TRADES – Please trade the below stocks at your own risk, DailyBubble is not responsible for your market choices. We are basing the below list on volatility, i.e. these stocks may present multiple opportunities to trade throughout the day. The below stocks are not guaranteed to go on a ‘run,’ as many would say; likewise, if a stock is reported, the ‘run’ may be multiple (1-3) days. Never trade or invest with more than you are willing to lose! Please make sure you have done your own Due Diligence. For further information, please review our Disclaimer policy.

Stocks on the move. (Under $1)

 $CYRN: (Stock News) No news to report on the movement. Volume for the day is 1,545,100 at 6:44 AM EST. It is currently up 25.18% since its last close.
Shares Outstanding: 75.48M Share Float: 37.58M


Stocks on the move. (Between $1-10)

$DNN: (Stock News) No news to report on the movement. Volume for the day is 461,000 at 6:47 AM EST. It is currently up 7.55% since its last close.
Shares Outstanding: 805.06M Share Float: 793.08M

$DSS: (Stock News) No news to report on the movement. Volume for the day is 108,000 at 6:51 AM EST. It is currently up 7.41% since its last close.
Shares Outstanding: 62.55M Share Float: 51.46M

$ENDP: (Stock News) Endo International shares rose 32.9% to close at $2.79 Friday after the company said it has settled three consolidated opioid cases pending in Suffolk County Supreme Court in the State of New York. As a result of the settlement, Endo has been severed from the trial. Volume for the day is 188,000 at 6:58 AM EST. It is currently up 5.02% since its last close.
Shares Outstanding: 233.33M Share Float: 229..90M

$LPTX: (Stock News) Leap Therapeutics, Inc. a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced the Company will be presenting initial data from the first-line cohort of the DisTinGuish study, a Phase 2a clinical trial evaluating Leap’s anti-Dickkopf-1 (DKK1) antibody. Volume for the day is 920,000 at 6:37 AM EST. It is currently up 26.03% since its last close.
Shares Outstanding: 59.67M Share Float: 43.67M

$HEPA: (Stock News) Hepion Pharmaceuticals Inc stock is moving higher during premarket ahead of additional data from its non-alcoholic steatohepatitis (NASH) trial. Volume for the day is 745,000 at 6:44 AM EST. It is currently up 15.06% since its last close.
Shares Outstanding: 76.22M Share Float: 76.12M


Stocks on the move. (Above $10)

 $ATER: (Stock News) No news to report on the movement. Volume for the day is 564,400 at 6:46 AM EST. It is currently up 11.86% since its last close.
Shares Outstanding: 29.55M Share Float: 24.22M

 $AMC: (Stock News) Meme stocks AMC & GME push small-cap benchmark higher. Volume for the day is 257,100 at 6:51 AM EST. It is currently up 11.86% since its last close.
Shares Outstanding: 496.55M Share Float: 448.56M

 $BBIG: (Stock News) No news to report on the movement. Volume for the day is 213,700 at 6:52 AM EST. It is currently up 2.42% since its last close.
Shares Outstanding: 35.83M Share Float: NA

 $SPRT: (Stock News) SPRT declined 19.3% to close at $21.00 after stockholders approved the merger with Greenidge Generation Holdings Inc. Volume for the day is 118,600 at 6:56 AM EST. It is currently up 3.81% since its last close.
Shares Outstanding: 24.15M Share Float: 15.08M

 $ISEE: (Stock News) Shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic atrophy. IVERIC Bio, a competitor to Apellis, is also working on a product to treat geographic atrophy, called Zimura. Stifel initiated coverage on IVERIC bio with a Buy rating and announced a price target of $22. Volume for the day is 86,115 at 6:57 AM EST. It is currently up 0.35% since its last close.
Shares Outstanding: 93.41M Share Float: 59.20M

 

DailyBubble’s Disclaimer
This article provided by the DailyBubble team should only be considered as informational and/or entertainment by the reader. DailyBubble makes no representation to buy or sell any security or financial instrument within the article. Readers seeking investment advice should seek independent financial advice from a professional, and independently research and verify. The DailyBubble team wrote this article and may express its own opinions therein.

Related Articles

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments